Emerging ideas: treatment of precollapse osteonecrosis using stem cells and growth factors

Area of Science:

• Biomedical Engineering
• Regenerative Medicine
• Orthopedic Research

Background:

• Osteonecrosis (ON) of the femoral head severely impacts young, productive individuals, leading to significant socioeconomic burdens.
• The exact pathogenesis of ON remains unknown, but it's often linked to microvascular compromise, bone cell death, and impaired repair.
• Current treatments for precollapse ON are limited, highlighting the need for novel therapeutic strategies.

Purpose of the Study:

• To investigate the potential of genetically engineered bone marrow stem cells delivering vascular endothelial growth factor (VEGF) and bone morphogenetic protein-6 (BMP-6) for treating femoral head ON.
• To assess if this approach can reverse the disease process by enhancing angiogenesis and osteogenesis in necrotic bone.
• To develop an injectable bone graft substitute for effective ON treatment.

Main Methods:

• Utilizing genetically engineered bone marrow stem cells carrying VEGF and BMP-6 genes for local delivery.
• Employing an animal model of ON to evaluate stem cell integration, osteogenesis, and angiogenesis.
• Quantitatively assessing bone repair using high-resolution X-ray CT and immunohistomorphometry, and evaluating mechanical properties via indentation testing.

Main Results:

• (Study is proposed, results not yet available)

Conclusions:

• A novel bone graft substitute incorporating engineered stem cells and therapeutic growth factors is envisioned.
• This approach holds promise for providing a much-needed treatment for osteonecrosis (ON) of the femoral head.
• Successful development could significantly improve outcomes for patients with precollapse ON.